首页> 外国专利> DONOR HEMATOPOIETIC CELL CHIMERISM AND ORGAN AND TISSUE TRANSPLANTATION AND AUTOIMMUNE TOLERANCE

DONOR HEMATOPOIETIC CELL CHIMERISM AND ORGAN AND TISSUE TRANSPLANTATION AND AUTOIMMUNE TOLERANCE

机译:供体造血细胞嵌合体与器官组织移植及自身免疫耐受

摘要

Compositions and methods are provided for the achievement of organ and tissue transplantation and autoimmune tolerance using the infusion of living and/or deceased donor hematopoietic cells. The methods provided herein provide for conditioning with a plurality of doses of total lymphoid irradiation (TLI), and a single, very low dose of TBI (svldTBI), referred to herein as "TLI-svldTBI-ATG" or "TLI-svldTBI" depending on whether ATG is included. The combination of svldTBI and TLI specifically targets non-lymphoid-tissue resident memory immune cells. An in vitro manipulated donor cell composition is provided for use with the conditioning regimen, in which specific ratios of CD34+ and other hematopoietic stem cell and precursor cell populations are combined with defined doses of CD3+ T cells, and/or purified regulatory T cells (Treg) cells, invariant natural killer (iNK-T) cells, and/or CD8+ memory T cells.
机译:本发明提供了用于通过输注活体和/或已故供体造血细胞实现器官和组织移植及自身免疫耐受的组合物和方法。本文提供的方法提供了用多剂量的全淋巴照射(TLI)和单剂量极低剂量的TBI(svldTBI)进行调节,根据是否包括ATG,本文称为“TLI svldTBI ATG”或“TLI svldTBI”。svldTBI和TLI的组合专门针对非淋巴组织驻留记忆免疫细胞。本发明提供了一种用于预处理方案的体外操纵供体细胞组合物,其中CD34+和其他造血干细胞及前体细胞群的特定比率与规定剂量的CD3+T细胞、和/或纯化调节性T细胞(Treg)细胞、不变自然杀伤细胞(iNK-T)细胞和/或CD8+记忆性T细胞结合。

著录项

相似文献

  • 专利
  • 外文文献
  • 中文文献
获取专利

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号